UPDATE - Gain Therapeutics' GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson's Disease -February 06, 2024 at 09:56 am EST

Data presented at 20th WORLDSymposium™ show progressive reversal of motor deficit and corresponding reduction of neurodegeneration biomarker NfL to level of control armBETHESDA, Md., Feb. 06, 2024 ...

Related Keywords

San Diego ,California ,United States ,Elio Ambrosio ,Nic Johnson ,Matthias Alder ,Exchange Commission ,Drug Administration ,Company Annual Report On Form ,Nasdaq ,Gain Therapeutics Inc ,Exchange Commission On ,Michaelj Fox Foundation For Parkinson Research ,Silverstein Foundation For Parkinson ,Linkedin ,Gain Therapeutic Chief Executive ,Neurofilament Light Chain ,Silverstein Foundation ,Gain Therapeutics ,Site Directed Enzyme Enhancement Therapy ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,